AI Bubble Watch on Palantir
Stock markets wanted to blame reports of a potential budget cut by the Department of Defense for the drop in Palantir Technologies (PLTR) shares. Last week, Palantir stock peaked at around $125 but closed at $101.35 on Feb. 22. The software firm previously enjoyed a relentless uptrend after the S&P 500 (SPY) added it to the index.News of the potential DOD spending cut hurt shares of Oracle (ORCL), Cloudflare (NET), Fortinet (FTNT), Workday (WDAY), Salesforce (CRM), Salesforce (CRM), and MongoDB (MDB).Insider selling may explain the sudden drop in Palantir stock. CEO Karp has a net worth of $10.2 billion. He is actively selling Palantir stock. In 2024, he sold $1.95 billion worth of stock. He filed plans to sell up to $1.2 billion more this year. Those are significant sales but should not surprise markets.Investors may take a look at the pullback in PLTR stock as a potential opportunity. Defense Secretary Pete Hegseth suggested cutting 8% of the defense budget in each of the next five years. However, Russia’s threat will only worsen if the U.S. spends less on this industry. The government may conclude that a cost cut of that size is not possible. China is spending more. To stay ahead, the U.S. may need to continue buying solutions that Palantir offers.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


